Most founders preparing an institutional round answer the wrong question. The question they ask is "am I ready?" The question partners answer is "where does this business sit, and what is the pricing on that specific position?" Those are not the same question, and the gap between them is where most rounds either close cleanly or drag out into a valuation fight nobody wanted.
Partners do not look at your business and decide if it is good. They decide which of a small number of familiar positions it is in — and the pricing follows the position. A business in the pre-institutional position prices one way. A business in the Series B efficiency position prices a different way. A business that sits in the bridge-round position prices on a third logic entirely. The founders who walk into the room knowing which position they are being priced from get to negotiate. The founders who do not, get priced.
Round readiness is not a yes/no question. It is a five-state map. The partner across the table is matching your business to one of the five — the only useful question is which state the evidence points to, and what pricing that state attracts.
The Round Readiness Diagnostic is the structured view of that question. Eight minutes. Twelve drivers. One of five recommended states. Free to run.
Every founder preparing an institutional round sits in one of five positions. Each position has its own evidence pattern, its own pricing logic, and its own conversation. Running the diagnostic tells you which one the evidence currently routes you to — and, just as importantly, which ones you are not in.
The business is building. The drivers are present but not yet at the level partners need to underwrite an institutional cheque. The right work here is not pitching — it is building the asset base so the next round is a different conversation. Founders in this state who push into an institutional process anyway tend to burn relationships with partners who would have said yes eighteen months later.
The drivers are there. The evidence is structured. The business has either already reached or is within a quarter of the metrics partners use to decide. The work is making the data-room and the diligence story match the reality. This is the position most founders assume they are in. Most are not — which is why the diagnostic matters.
Partners at this stage are pricing efficiency, not growth. Rule of 40 in the mid-to-high 40s. NRR in the 120s. Burn multiples below 1.5. The drivers that carry the weight are customer capital depth, pricing architecture, and operational leverage. Running the diagnostic early — twelve to eighteen months before the round — is how founders in this state move the underlying drivers rather than hoping the metrics will come with time.
The business is strong but the next institutional round is six to twelve months away and cash needs to carry the intervening work. The conversation is not about product-market fit or growth — it is about a thesis for the deployment of bridge capital and a credible path to the next priced round. Existing investors underwrite on the thesis; new leads underwrite on the asset base.
The term sheet came in, the valuation came in below where the evidence warranted, and the founder has to decide whether to accept, push back, or walk. The diagnostic here gives structured evidence for the pushback — which drivers justify the valuation the business deserves, and which are genuinely weak. This is the state most founders arrive in without language to defend the number.
The diagnostic is not a questionnaire. It is a structured view of twelve intangible drivers — the asset base that partners underwrite when they price a round. Each driver is scored on the evidence the founder provides, and the combined score routes the business to one of the five states above using a deterministic matrix.
Customer capital, product stickiness, pricing architecture, brand equity, workforce capability, operational infrastructure, IP position, data assets, partnership ecosystem, regulatory position, financial discipline, and strategic narrative. Each scored zero to ten on the evidence.
A blended score across the twelve drivers, with the weighting partners apply to the drivers that matter most at each round stage.
A deterministic routing matrix maps the combined evidence to one of the five founder states — the state the business is actually in, not the state the founder believes they are in.
Which of the twelve drivers is materially weaker than the others. For most businesses moving between states, one or two drivers carry the whole gap — and the work is intervening on those specifically rather than trying to move everything at once.
The state-specific playbook: the evidence the partners in that position will underwrite, the drivers to move first, and the timeline the work takes. Not a generic "improve your pitch" — the specific intervention for the specific state.
The twelve drivers are the foundation. Partners do not all use the same taxonomy, but when you decompose the questions they actually ask across the diligence process, they map to this set. The diagnostic makes the mapping explicit so the founder can see what is being priced and where the weight sits.
A SaaS founder preparing a Series A ran the diagnostic and scored well on product and workforce but weakly on customer capital depth — the drivers behind NRR and expansion behaviour. The diagnostic routed the business to pre-institutional rather than Series A, with the binding constraint on customer capital. The founder spent six months building the customer-success ops function rather than pitching. The round that closed fourteen months later priced a different business.
Most fundraising advice starts with the deck and works backwards. The diagnostic starts with the asset base and works forwards. This matters because the deck is the output of the asset base, not the other way round. A polished deck on a weak asset base produces a round that closes slowly, at a poor valuation, with a difficult board. A structured asset base produces a deck that writes itself, because every claim on every slide has evidence behind it.
The diagnostic is not a replacement for the pitch. It is the layer underneath the pitch that determines whether the pitch has anything to land on.
Every founder on the Founder Free plan can run the diagnostic once, for life. Pre-Seed users can run it three times. Starter plans and above run it unlimited. The reason it exists on the free tier is simple: the diagnostic is the honest starting point, and honest starting points cannot be paywalled. If the evidence routes a founder to pre-institutional when they thought they were Series A-ready, that is a conversation worth having before any money changes hands — on either side.
The diagnostic is a starting view, not a final report. It uses the founder's own input for scoring, which means a founder who over-scores will get routed to a state that does not match the underlying evidence. Partners doing institutional diligence will probe the same drivers with documentary evidence, customer reference calls, and cohort data. The diagnostic works because founders who are honest in their own answers get honest recommendations — and those who are not, discover the gap in the diligence process at a much higher cost.
The diagnostic is designed for four founder audiences, each of whom gets a different conversation out of it.
This is the primary audience. The diagnostic gives the structured view of which drivers need to move, and the timeline for moving them, twelve to eighteen months before the round matters. Running it early is how Series A founders move the binding constraint rather than arriving at the round with a gap they cannot close in the last quarter.
The valuation-aggrieved state exists for this reason. The diagnostic produces the structured defence — the drivers the business actually has, the evidence behind them, and the comparables the partner should be pricing from. It does not guarantee a better term sheet, but it reframes the conversation from a negotiation to a data exchange.
The bridge state requires a different thesis from a priced round. The diagnostic routes bridge-state founders to the thesis construction work specifically — the four-component bridge structure that gets existing holders to participate and new leads to commit. (See How to build a bridge-round thesis that closes.)
Investors running an advisory relationship with a founder often need a structured view of round-readiness for a portfolio company that is neither their lead nor their deal. The diagnostic gives that view in eight minutes, routable across the portfolio. (Larger investor workflows are served by the investor portfolio and advisor views on the Starter plan and above.)
Round-readiness is a five-state map, not a yes/no question. The Round Readiness Diagnostic is the free, structured view of which state the evidence actually routes your business to — and what that state prices at. Eight minutes to know whether the next eighteen months of work is pitching, building, or pushing back. Run the diagnostic.
The diagnostic produces one of five state-specific destinations. Each one is a structured view of the work that state actually requires — not a generic playbook.
| State | Destination | Work |
|---|---|---|
| Pre-Institutional | /investor-ready/pre-institutional | Build the asset base before pitching |
| Series A | /series-a-readiness/ | Structure the evidence for institutional diligence |
| Series B | /series-b-readiness/ | Move the efficiency drivers 12–18 months out |
| Bridge | /bridge-rounds/ | Build a thesis that carries existing holders into the next round |
| Valuation-Aggrieved | /investor-ready/valuation-aggrieved | Structure the pushback against a low term sheet |
The diagnostic is deliberately scoped. It does not tell you how to run your business, and it does not predict whether a specific partner will say yes. It tells you which of five positions the evidence currently routes you to, and what the state-specific work is to either move states or prepare for the conversation that fits the current one.
That is the only question most founders are not answering before they start talking to partners. Eight minutes is a small price to answer it.
Run the Round Readiness Diagnostic
This is one of a series of articles on the Round Ready programme — structured preparation for institutional rounds, bridge rounds, and valuation defence. Related reading: The Series B efficiency bar in 2025 and why it moved · How to build a bridge-round thesis that closes · Building a valuation narrative for your next funding round.
The gap between what a company is worth and what it can prove it is worth is one of the most expensive problems in private markets. Opagio's valuation justification capability turns intangible asset data into an evidence-based narrative that bridges this gap.
Read more →
How founders and CFOs can use intangible asset data to justify stronger valuations and negotiate from evidence, not hope.
Read more →A step-by-step guide to filing retroactive R&D expense claims under Section 174A of the OBBBA. Covers eligibility, the amended return process, Section 280C coordination, and practical examples of tax impact — all before the July 6, 2026 deadline.
Read more →Get the latest insights on intangible asset growth and productivity delivered to your inbox.
Book a free consultation to see how Opagio Intangibles can help your business.